Elaine D Sun is SVP, Chief Financial Officer of HALOZYME THERAPEUTICS, INC.. Currently has a direct ownership of 14,018 shares of HALO, which is worth approximately $674,686. The most recent transaction as insider was on Apr 01, 2021, when has been sold 4,059 shares (Common Stock) at a price of $42.43 per share, resulting in proceeds of $172,223. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14K
0% 3M change
0% 12M change
Total Value Held $674,686

Elaine D Sun Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 01 2021
SELL
Payment of exercise price or tax liability
$172,223 $42.43 p/Share
4,059 Reduced 22.45%
14,018 Common Stock
Apr 01 2021
BUY
Exercise of conversion of derivative security
-
10,196 Added 36.06%
18,077 Common Stock
Mar 02 2021
SELL
Payment of exercise price or tax liability
$192,868 $45.01 p/Share
4,285 Reduced 35.22%
7,881 Common Stock
Mar 02 2021
BUY
Exercise of conversion of derivative security
-
12,166 Added 50.0%
12,166 Common Stock

Also insider at

DVAX
DYNAVAX TECHNOLOGIES CORP Healthcare
EDS

Elaine D Sun

SVP, Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on HALO

Follow HALOZYME THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HALO shares.

Notify only if

Insider Trading

Get notified when an Halozyme Therapeutics, Inc. insider buys or sells HALO shares.

Notify only if

News

Receive news related to HALOZYME THERAPEUTICS, INC.

Track Activities on HALO